A 24-month, Prospective, Non-interventional Study to Describe the Long Term, Real-Life Use of BOTOX for the symptomatic treatment of Adults with Chronic Migraine, Measuring Healthcare Resource Utilization, and Patient Reported Outcomes Observed in Practice.

Trial Profile

A 24-month, Prospective, Non-interventional Study to Describe the Long Term, Real-Life Use of BOTOX for the symptomatic treatment of Adults with Chronic Migraine, Measuring Healthcare Resource Utilization, and Patient Reported Outcomes Observed in Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms REPOSE
  • Sponsors Allergan
  • Most Recent Events

    • 27 Jun 2017 Results of REPOSE study presented at the 3rd Congress of the European Academy of Neurology.
    • 12 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 25 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top